Zealand Pharma A/S (CPH:ZEAL)
463.20
-2.20 (-0.47%)
Apr 3, 2025, 4:59 PM CET
Zealand Pharma Revenue
In the year 2024, Zealand Pharma had annual revenue of 62.69M DKK, down -81.71%. Zealand Pharma had revenue of 9.06M in the quarter ending December 31, 2024, a decrease of -61.02%.
Revenue
62.69M
Revenue Growth
-81.71%
P/S Ratio
n/a
Revenue / Employee
187.14K
Employees
335
Market Cap
32.73B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 290.40B |
Coloplast | 27.45B |
Genmab | 21.53B |
Demant | 22.42B |
H. Lundbeck | 22.00B |
Ambu A/S | 5.65B |
ALK-Abelló | 5.54B |
GN Store Nord | 17.99B |
Zealand Pharma News
- 7 days ago - Resolutions from Zealand Pharma's Annual General Meeting 2025 - GlobeNewsWire
- 9 days ago - Zealand Pharma major shareholder announcement: Van Herk Investments B.V. - GlobeNewsWire
- 14 days ago - Zealand Pharma increases its share capital as a result of the exercise of employee warrants - GlobeNewsWire
- 17 days ago - Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity - GlobeNewsWire
- 22 days ago - Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal - The Wall Street Journal
- 22 days ago - Roche agrees biggest-ever obesity drug deal - Financial Times
- 22 days ago - Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion - Investor's Business Daily
- 22 days ago - Roche And Zealand Team Up To Develop Petrelintide - Seeking Alpha